摘要
观察69例异基因骨髓移植患者,探讨环孢素A(CsA)谷浓度与急性移植物抗宿主病(aGVHD)和CsA相关毒副作用之间的关系。结果表明,Ⅱ~Ⅳ度aGVHD发生率为36.23%;Ⅱ~Ⅳ度aGVHD的发生与植活时的CsA谷浓度相关(P=0.0318);若谷浓度低于150μg/L,Ⅱ~Ⅳ度aGVHD发生率增加(P<0.05);当CsA谷浓度高于200μg/L时,CsA相关的肝、肾毒副作用发生率明显上升(P<0.05)。认为将CsA谷浓度尤其是植活时的谷浓度维持在150~200μg/L,可以提高CsA的效果,并降低CsA的肝、肾毒副作用发生率。
Sixty-nine patients undergoing heterologous transplantation were retrospectively analyzed to investigate the relationship between toxicity and adverse effects of cyclosporine A (CsA) and acute graft versus host disease (GVHD). The results showed that the incidence of acute GVHD with Ⅱ ̄Ⅳ grade ( 36.23% ) was related to the trough concentration of CsA ( P = 0.031 8 ). The incidence of acute GVHD with Ⅱ ̄Ⅳ grade increased with the CsA trough concentration less than 150μg/L. The incidence of toxicity and adverse effects on liver and kidney was obviously increased with the CsA trough concentration over 200μg/L( P < 0.05 ). It was suggested that the optimal trough concentration of CsA was 150 ̄200μg/L, which might improve the therapeutic effects of CsA and reduce the incidence of toxicity and adverse effects on liver and kidney.
出处
《中华器官移植杂志》
CAS
CSCD
1998年第1期39-41,共3页
Chinese Journal of Organ Transplantation
关键词
骨髓移植
移植物抗宿主病
环孢素A
异体移植
Bone marrow transplantation, heterologous Graft vs host disease Monitoring, pharmacology